Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Grieger KM"'
Autor:
Beneke V; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany., Grieger KM; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany., Hartwig C; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany., Müller J; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.; Center of Integrative Bioinformatics Vienna (CIBIV), Max Perutz Labs, University of Vienna and Medical University of Vienna, Vienna BioCenter, Vienna, Austria.; Member of the Vienna Biocenter PhD Program, University of Vienna and the Medical University of Vienna, Vienna, Austria., Sohn K; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany., Blaudszun AR; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Hilger N; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Schaudien D; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany., Fricke S; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Braun A; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Institute for Immunology, Hannover Medical School, Hannover, Germany., Sewald K; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany., Hesse C; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Publikováno v:
European journal of immunology [Eur J Immunol] 2024 Aug; Vol. 54 (8), pp. e2350946. Date of Electronic Publication: 2024 May 19.